Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ADIL
#4023
Adial Pharmaceuticals, Inc
2.5
3
+3.27%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+3.27%
Changement Mensuel
+1000.00%
Evolution sur 6 mois
+548.72%
Changement Annuel
+232.89%
Clôture Précédente
2.4
5
Open
2.5
3
Bid
Ask
Low
2.5
3
High
2.5
3
Volume
1
Marchés
Actions des Marchés US
Soins de Santé
ADIL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.63 K
37.95 K
45.63 K
162.19 K
262.98 K
—
Valuation ratios
Enterprise value
—
—
—
-2.54 M
-3.48 M
-15.57 M
Price to earnings ratio
—
—
—
-0.02
-0.01
-0.16
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
-0.01
-0.03
-0.07
Price to book ratio
—
—
—
0.02
0.05
0.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.98
-2.6
-2.22
-1.08
-2.62
-1.66
Return on equity %
2.73
-5.54
-3.89
-1.25
-3.24
-2.31
Return on invested capital %
12.16 K
-10.75 K
-4 697.79
-1 964.47
-2 507.23
—
Gross margin %
100
100
—
—
—
—
Operating margin %
2 906.38
-41.49 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
2 897.07
-41.78 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
4.2
3.69
—
Current ratio
3.41
2.37
2.67
4.9
4.16
15.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.06
0.01
0
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
0.01
—
—
—
Long term debt to total equity ratio
—
0.01
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
-279.23
-119.45
-35.67
-19.74
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
99.89
49.61
19.33
47.49
Net current asset value per share
—
—
119.32
56.13
20.92
50.93
Tangible book value per share
—
—
75.46
71.59
20.95
47.29
Working capital per share
—
—
74.61
44.67
15.89
36.68
Book value per share
—
—
81.79
71.66
20.96
47.33
Nouvelles
Le titre d’Adial Pharmaceuticals progresse suite à un changement de politique de la FDA
Adial Pharmaceuticals stock rises on FDA policy shift
Adial Pharmaceuticals envisage un essai clinique pivot unique pour AD04
Adial Pharmaceuticals eyes single pivotal trial path for AD04
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com
L’action d’Adial Pharmaceuticals chute après l’annonce d’un regroupement d’actions de 1 pour 25
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split
Adial Pharmaceuticals annonce un regroupement d’actions à raison de 1 pour 25
Adial Pharmaceuticals announces 1-for-25 reverse stock split
Adial Pharmaceuticals annonce la démission de l’administrateur James W. Newman, Jr.
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?